HER LAWYERS WARNED OF THE DANGERS. NOW, NEW DETAILS REVEAL THE RARE CANCER BEHIND CHRISTA PIKE’S BOTCHED EXECUTION

Christa Pike’s attorneys warned months before her scheduled execution that a rare blood disorder and difficulties accessing her veins could make the procedure especially dangerous.

Months before Tennessee attempted to execute Christa Pike, her legal team had already raised serious concerns about her medical condition.

According to a January 2026 court filing obtained by PEOPLE, Pike’s attorneys warned that she had a rare blood disorder associated with cancer that could increase the risks of complications during a lethal injection.

Those concerns have drawn renewed attention following the failed execution attempt on September 30, when officials reportedly struggled to establish intravenous lines and Pike survived two rounds of execution drugs.

A RARE BLOOD DISORDER RAISED CONCERNS

In their January filing, Pike’s attorneys stated that she had significantly elevated platelet levels, a condition known as thrombocytosis.

They said the condition was likely linked to myeloproliferative disorder, a rare form of blood cancer affecting the body’s production of blood cells.

Her lawyers argued that the elevated platelet count could increase the risk of severe pulmonary edema — a dangerous buildup of fluid in the lungs.

According to the legal filing, such a complication could cause extreme physical distress, including a sensation of suffocation.

The attorneys argued that proceeding with the planned execution without properly addressing these medical risks could expose Pike to unnecessary pain and suffering.

HER LAWYERS ALSO WARNED ABOUT DIFFICULTIES WITH NEEDLES

The court document raised another concern: Pike’s history of difficulty with blood draws and needle insertion.

According to the filing, prison medical staff had used butterfly needles when drawing her blood.

Her attorneys argued that this type of needle could provide a safer alternative during medical procedures, potentially reducing the risk of unnecessary injury and pain.

They also challenged Tennessee’s updated execution protocol, saying it did not guarantee that attorneys would have immediate telephone access to the courts before or during the procedure.

They argued that such access was essential if serious problems developed during the execution.

THE WARNINGS WERE FOLLOWED BY A FAILED EXECUTION

On September 30, Tennessee attempted to carry out Pike’s execution at Riverbend Maximum Security Institution.

According to reports, execution personnel struggled to establish working IV lines before administering two rounds of lethal-injection drugs.

Pike did not die. Instead, she was taken to the hospital, where she remained for 10 days before being transferred back to the Debra K. Johnson Rehabilitation Center.

The events brought renewed scrutiny to the concerns her attorneys had raised months earlier.

HER FUTURE REMAINS UNCERTAIN

Following the failed execution, Pike’s attorneys filed an emergency motion seeking to end her continued isolation in prison.

PEOPLE reported that she was spending most of her days in solitary confinement after returning to the facility.

Tennessee Gov. Bill Lee suspended the state’s remaining scheduled executions for 2026 and ordered an independent investigation into what happened.

Pike, now 50, was sentenced to death for the 1995 murder of 19-year-old Colleen Slemmer. She was 18 at the time of the crime.

The case has since raised renewed questions about the medical risks identified before the execution, the procedures followed that night and what will happen next.

For now, Pike remains in prison as the legal proceedings and independent review continue.

The warnings had been made months earlier. But the failed execution has left serious questions about whether those concerns were adequately addressed.